Transgene
www.transgene.frCancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer.
Read more
Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer.
Read more
Country
City (Headquarters)
Illkirch-Graffenstaden
Industry
Founded
1979
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Industrial Partners Manager / External Manufacturing and Cmc - Chief Marketing Officer Manager
Email ****** @****.comPhone (***) ****-****Senior Director , Head Infectious Diseases
Email ****** @****.comPhone (***) ****-****Co - Director of the Connected Health Responsibility Center - Heart Pole - Vessels - Bichat Hospital
Email ****** @****.comPhone (***) ****-****Head of Laboratory Biological Imaging
Email ****** @****.comPhone (***) ****-****
Technologies
(23)
Reach decision makers at Transgene
Free credits every month!
Transgene FAQ
Illkirch-Graffenstaden, France
Biotechnology Research
